ACG and ASGE have issued recommendations on quality indicators for colonoscopy, the gold standard for colorectal cancer screening (CRC).
Tag: Colonoscopy
Offering Both Colonoscopy and At-Home Tests Doubled Colorectal Cancer Screening
In a trial analyzing how messages were framed in an underserved population, offering colorectal cancer screening options resulted in the highest screening rate
Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients
Colonoscopy is often recommended following an episode of diverticulitis to exclude missed colorectal cancer (CRC). Now one study, published in the Clinical Gastroenterology and Hepatology journal, shows that the prevalence of CRC is low in most patients with diverticulitis. However, patients with complicated diverticulitis are the exception.
Deeper sedation may help find difficult-to-detect polyps during colonoscopy
In patients undergoing colonoscopy to screen for colorectal cancer, deeper sedation using the anesthetic drug propofol may improve detection of “serrated” polyps — a type of precancerous lesion that can be difficult to detect, reports a study in the Online First edition of Anesthesiology, the peer-reviewed journal of the American Society of Anesthesiologists (ASA).
Grand Prize Winner: The Southwest Coalition for Colorectal Cancer Screening (SuCCCeS) program
According to the American Cancer Society, the number of colorectal cancers in the US for 2024 are estimated to be about 106,590 new cases of colon cancer (54,210 in men and 52,380 in women) and about 46,220 new cases of rectal cancer (27,330 in men and 18,890 in women).
Studies on Higher Infliximab Concentrations in IBD, Opioid-Related Constipation and More in the November Issue of AJG
The November issue of AJG highlights new clinical science and reviews including additional colonoscopy quality measures, higher infliximab concentrations in IBD patients with higher visceral adipose tissue (VAT), an automated tissue systems pathology test for Barrett’s esophagus, and opioid-related constipation.
Baylor Scott & White Shares Insights At ACG Annual Scientific Meeting 2023
The 2023 American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course will convene in Vancouver, Canada, Oct. 20-25. The ACG is a recognized leader in educating GI professionals and the public about digestive disorders. The ACG’s mission is…
Should older adults with fewer years to live keep getting cancer screenings? Poll explores attitudes
A majority of older adults disagree with the idea of using life expectancy as part of guidelines that say which patients should get cancer screenings such as mammograms and colonoscopies, a new poll finds.
Two studies demonstrate the benefits and limitations of artificial intelligence in colonoscopy
New research published in Annals of Internal Medicine explores the possible benefits and limitations of using computer assistance, or artificial intelligence, in detecting lesions and cancer during colonoscopy.
Cancer screenings have saved the U.S. at least $6.5 trillion, study estimates
Americans have gotten at least 12 million more years of life to live because of preventive cancer screenings they’ve gotten the past 25 years, a new study estimates. That adds up to at least $6.5 trillion in added economic impact, because of scans and tests that look for early signs of breast, colon, cervical and lung cancer in adults at the highest risk.
May Issue of AJG Features Colonoscopy Quality and Bowel Prep, CME on Social Media
The May issue of AJG features new clinical science and reviews, including bowel prep recommendations for physicians, longer withdrawal times for screening colonoscopy, the use of social media for continuing medical education, and tofacitinib de-escalation and re-escalation for ulcerative colitis.
Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk in a FIT-based screening program
A cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant inverse association between endoscopists’ proficiency as measured by adenoma detection rate (ADR) and post-colonoscopy colorectal cancer (PCCRC). These finding suggest that targeting only poor performing endoscopists with measures to increase ADR may significantly reduce PCCRC risk. The findings are published in Annals of Internal Medicine.
Cold snare polypectomy significantly reduces bleeding risk compared to hot snare polypectomy
A randomized controlled trial (RCT) of more than 4,000 people found that the risk for delayed bleeding after polypectomy was significantly reduced among persons who received a cold snare polypectomy. The findings are published in Annals of Internal Medicine.
DeepGI AI – A Thai Innovation for the Precision in Colorectal Polyp Detection
Chula Engineering and Chula Medicine co-invent an innovative device for a rapid gastrointestinal cancer detection that yields accurate results hoping to foster preventive medicine in gastrointestinal malignancy and reduce the number of cancer patients.
New Research Finds Computer Assisted Colonoscopy Identify More Precancerous Polyps Compared to Traditional Colonoscopy
Colonoscopies performed with artificial intelligence saw an increase in the overall rate of detection of adenoma, or cancerous and precancerous polyps, according to new data presented at the 2022 Digestive Disease Week Annual Meeting.
First-of-its-kind study: Use of computer-assisted colonoscopies reduces rate of missed lesions
In the first randomized trial examining the role of a deep-learning based computer-aided detection system during colonoscopy in the U.S., researchers reported a relative reduction of the miss rate by nearly a third when computer-aided detection was used in conjunction with standard-of-care colonoscopy.
The Medical Minute: Colonoscopy comes calling earlier under new screening guidelines
Evolving evidence shows screening tests should actually start at age 45 for people at average risk for colorectal cancer. Two Penn State Health doctors discuss new guidelines.
Colonoscopy: Yes, This is a Test
Colorectal cancer is the second leading cause of cancer death for both men and women, according to the Centers for Disease Control and Prevention (CDC), even though 90 percent of people who are diagnosed through early testing can be cured.
Putting the Spotlight on Colorectal Cancer Risk and Prevention during Colorectal Cancer Awareness Month
Colorectal Cancer Screening Saves Lives Colorectal cancer is the third most common cause of cancer related death for both men and women. However, if it is caught early, colorectal cancer has a 90% survival rate. This is why screening is…
Year or More Delay Between Abnormal, At-Home Screening and Colonoscopy Increases Cancer Risk
A new study by researchers at University of California San Diego School of Medicine found delayed time between abnormal stool-based screening and subsequent colonoscopy was associated with an increased risk of a cancer diagnosis and death from colorectal cancer.
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic
High-risk Patients for Colorectal Cancer Lack Knowledge About Colonoscopy
Many clinicians rely on self-reports from their high-risk patients about their need and proper interval for repeat surveillance colonoscopy. Researchers analyzed data over four years to explore the knowledge of these high-risk patients. Twenty-eight percent were unaware of either the need for a repeat colonoscopy or the proper surveillance interval. Of these, 16.6 percent were unaware of the proper three-year interval to obtain a follow-up surveillance colonoscopy. Also, 12 percent were not even aware that they required a follow-up surveillance colonoscopy.
Dropping it in The Mail: Best Practices Detailed For Mail-In Colon Cancer Screenings
DALLAS – Sept. 8, 2020 – A program that asks patients to mail in stool samples to screen for colon cancer is an effective way to expand screenings to underserved and underinsured communities and offers an alternative to in-person testing during the pandemic, according to a study conducted by UT Southwestern.
MSK: Cancer Isn’t Sheltering in Place
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, Memorial Sloan Kettering Cancer Center oncologists are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed treatments could be devastating for patients and their loved ones across the region and the country.
March 2020 Issue of The American Journal of Gastroenterology Includes Complementary & Alternative Therapies for Functional GI Disorders
The March issue of The American Journal of Gastroenterology features evidence-based articles related to complementary and alternative medicine therapies for functional GI disorders, a new ACG Clinical Guideline for the diagnosis and management of Chronic Pancreatitis, opioid-related constipation, and more.
Colorectal Cancer Q&A: The Truth about Screening, Prevention, and More
A colonoscopy is the best way to screen for and prevent colorectal cancer (CRC) because it allows your doctor to find and remove precancerous growths called polyps before they have a chance to turn into cancer.
The U.S. Preventive Services Task Force (USPSTF) recommends that most people have colonoscopy screenings starting at age 50. People who are at a higher risk for CRC due to family history or other factors should begin having screenings at a younger age based on their doctor’s recommendation.
Cologuard, an at-home test, is not a preventive CRC screening tool because it detects cancer after you develop it.
Beating Cancer – One Patient at a Time
Like most people, John Gifford wasn’t looking forward to a colonoscopy when he arrived on the UCI Medical Center campus in Orange in 2018. The Riverside man, 65, was concerned about his family history of colorectal cancer and had dutifully scheduled an appointment with UCI Health gastroenterologist Dr. William Karnes. The exam turned out to be intriguing and enlightening – a far cry from what one expects during a colonoscopy, Gifford recalls with a laugh.